Skip to main content
. 2022 Mar 21;9:774550. doi: 10.3389/fmed.2022.774550

Table 1.

Clinical characteristics of the 2215 participants in the COVAG study.

Characteristics Numbers*, **, ***
N = 2,215
Age, years* 39.9 ± 13.3, 38 (29-50)
Women** 1,211 (54.7)
Men** 1,004 (45.3)
Reason for testing
Referral from physician** 707 (31.9)
Referral from Health Department** 962 (43.4)
Miscellaneous** 546 (24.7)
Comorbidities
Any comorbidity** 499 (22.5)
No comorbidity** 1,716 (77.5)
Hypertension** 240 (10.8)
Dyslipoproteinaemia** 108 (4.9)
Diabetes mellitus** 49 (2.2)
COPD** 2 (0.8)
Ischaemic heart disease** 29 (1.3)
Clinical symptoms
Any clinical symptoms** 973 (43.9)
No clinical symptoms** 1,242 (56.1)
Malaise*** 632 (28.5, 65.0)
Shortness of breath*** 181 (8.2, 18.6)
Cough*** 459 (20.7, 47.2)
Fever*** 149 (6.7, 15.3)
Diarrhoea*** 154 (7.0, 15.8)
Musculoskeletal pain*** 354 (16.0, 36.4)
Headache*** 597 (27.0, 61.4)
Nausea*** 129 (5.8, 13.3)
Vaccination status
Not vaccinated** 2,016 (91)
Vaccinated** 198 (8.9)
Unknown** 1 (0)
Vital signs (binary)
SysBP > 130 mmHg and/or DiasBP > 90 mmHg* 876 (39.5)
Other blood pressures* 1,339 (60.5)
Body temperature > 37°C* 28 (1.3)
Body temperature ≤ 37°C* 2,187 (98.7)
Oxygen saturation > median* 281 (12.7)
Oxygen saturation ≤ median* 1,934 (87.3)
Vital signs (metric)
Systolic blood pressure, mmHg* 130 ± 20.2, 130 (115-140)
Diastolic blood pressure, mmHg* 81 ± 11.3, 80 (70-90)
Body temperature, °C* 36.1 ± 0.6, 36.2 (36-36.4)
Oxygen saturation, %* 97.2 ± 3.3, 98 (97-98)

Data are given as n (%) or mean ± SD with median (25%, 75%).

*

Means ± standard deviations and medians (25th and 75th percentile).

**

Numbers and percentages based on the entire cohort (n = 2,215).

***

Numbers and percentages based on the entire cohort (n = 2,215) and referring to patients with at least one clinical symptom.